|   From the Trenches

Call Me, Maybe


My first job at a public company was when I joined Biogen or Biogen Idec as it was then called. One of the rituals of the team was to listen in to the quarterly earnings calls, usually on speaker in a conference room as we drank our morning cup of joe and caught up on emails. It was interesting to hear company leaders describe R&D progress and the quarterly performance figures but the best bit was the incisive analyst questions.

This blog post was written by Aoife Brennan, CEO of Synlogic, as part of the From The Trenches feature of LifeSciVC.

Read more.